Detection of broad functional gag-specific CD4+T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen

Detection of broad functional gag-specific CD4+T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen

Detaylı Bibliyografya
Asıl Yazarlar:	Ondondo, B, Yang, H, Dong, T, de Gleria, K, Suttill, A, Conlon, C, Brown, D, Williams, P, Bowness, P, Rowland-Jones, S, Hanke, T, McMichael, A, Dorrell, L
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	2006

Benzer Materyaller

Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
Yazar:: Rowland-Jones Sarah L, ve diğerleri
Baskı/Yayın Bilgisi: (2006-12-01)

Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.
Yazar:: Ondondo, B, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
Yazar:: Dorrell, L, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.
Yazar:: Dorrell, L, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.
Yazar:: Dorrell, L, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

pTHr.HIVA and MVA.HIVA vaccines (gag p24/p17) augment CD4+T cell responses in chronically infected HIV-1 patients on HAART
Yazar:: Ondondo, B, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia.
Yazar:: Ondondo, B, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2.
Yazar:: Tamara Kusay Jabbar, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

HIV-gag-specific cytotoxic T lymphocytes.
Yazar:: Nixon, D, ve diğerleri
Baskı/Yayın Bilgisi: (1989)

Gag-Gag Interactions Are Insufficient to Fully Stabilize and Order the Immature HIV Gag Lattice
Yazar:: Ipsita Saha, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

HIV-1 subtype A gag variability and epitope evolution
Yazar:: Abidi, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.
Yazar:: Rolland, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

HIV-1 subtype A gag variability and epitope evolution.
Yazar:: Syed Hani Abidi, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy.
Yazar:: Yang, H, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.
Yazar:: Morgane Rolland, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)

The Life-Cycle of the HIV-1 Gag–RNA Complex
Yazar:: Elodie Mailler, ve diğerleri
Baskı/Yayın Bilgisi: (2016-09-01)

Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity
Yazar:: Kazuaki Monde, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice.
Yazar:: Ros Chapman, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen
Yazar:: Singh V, ve diğerleri
Baskı/Yayın Bilgisi: (2012-09-01)

Gag and protease co-evolution modeling for HIV-1
Yazar:: Wang, Junjie
Baskı/Yayın Bilgisi: (2014)

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
Yazar:: Shephard Enid G, ve diğerleri
Baskı/Yayın Bilgisi: (2011-10-01)

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
Yazar:: Klenerman, P, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
Yazar:: Chinh Tran-To Su, ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys
Yazar:: Jiang, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects.
Yazar:: Howles, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

3D structural modeling of HIV-1 GAG protein
Yazar:: Xu, Xiao Yan.
Baskı/Yayın Bilgisi: (2011)

Recent Advances in HIV-1 Gag Inhibitor Design and Development
Yazar:: Alexej Dick, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Relationship between HIV-1 Gag Multimerization and Membrane Binding
Yazar:: Christopher Sumner, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.
Yazar:: Reid, S, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

IQGAP1 Negatively Regulates HIV-1 Gag Trafficking and Virion Production
Yazar:: Yosef Sabo, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Four novel cytotoxic T-lymphocyte epitopes in the highly conserved major homology region of HIV-1 Gag, restricted through B*4402, B*1801, A*2601, B*70 (B*1509)
Yazar:: Ogg, G, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

HIV-1 with gag processing defects activates cGAS sensing
Yazar:: Rebecca P. Sumner, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

New Insights Into Retroviral Gag-Gag and Gag-Membrane Interactions
Yazar:: Jose eMaldonado, ve diğerleri
Baskı/Yayın Bilgisi: (2014-06-01)

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
Yazar:: Nixon, D, ve diğerleri
Baskı/Yayın Bilgisi: (1988)

Role of Gag in HIV Resistance to Protease Inhibitors
Yazar:: Fabrizio Mammano, ve diğerleri
Baskı/Yayın Bilgisi: (2010-07-01)

Kinetic Studies on the Interaction of HIV-1 Gag Protein with the HIV-1 RNA Packaging Signal
Yazar:: Constance Rink, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
Yazar:: Podola L, ve diğerleri
Baskı/Yayın Bilgisi: (2012-09-01)

Population-specific evolution of HIV Gag epitopes in genetically diverged patients.
Yazar:: Abidi, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Binding mechanism of the matrix domain of HIV-1 gag on lipid membranes
Yazar:: Viviana Monje-Galvan, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Structural and molecular determinants of HIV-1 Gag binding to the plasma membrane
Yazar:: Jiri eVlach, ve diğerleri
Baskı/Yayın Bilgisi: (2015-03-01)